Jon R. Levine - Oct 27, 2022 Form 4 Insider Report for MARIMED INC. (MRMD)

Role
CFO, Treasurer and Secretary, Director, 10%+ Owner
Signature
/s/ Jon R. Levine
Stock symbol
MRMD
Transactions as of
Oct 27, 2022
Transactions value $
$0
Form type
4
Date filed
10/31/2022, 05:19 PM
Previous filing
Jan 14, 2022
Next filing
Mar 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MRMD Common stock 20M Oct 27, 2022 Direct
holding MRMD Common stock 6.68M Oct 27, 2022 By the Jon Levine Family Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRMD Restricted Stock Units (RSU) Award $0 +833K $0.00 833K Oct 27, 2022 Common Stock, par value $.001 per share 833K Direct F2, F3
holding MRMD Option to buy common stock 5M Oct 27, 2022 Common Stock, par value $.001 per share 5M $0.90 Direct F4
holding MRMD Option to buy common stock 5M Oct 27, 2022 Common Stock, par value $.001 per share 5M $0.88 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held in trust for the benefit of the reporting person's spouse and children. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F2 The RSUs were granted to the Reporting Person in accordance with Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended. Each RSU represents a contingent right to receive one share of the Issuer's common stock. RSUs convert to common stock on a one-for-one basis.
F3 The RSUs vest over a three year period in equal one-sixth installments every six months following the October 27, 2022 grant date, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.
F4 Immediately.